SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Frostman who wrote (5344)2/8/1998 9:49:00 PM
From: Tunica Albuginea  Read Replies (2) of 23519
 
Frosty, I've had some EXCELLENT news on Vivus Phase IV clinical trials, ie trials in the hands of practicing physicians,gg! However I don't want to spill the beans yet. I haven't seen these data posted yet in the Web. I'll wait till a rainy day when Vivus price is down (from the usual crowd playing with the stock ), gg. If Vivus goes down further it will be a great buying opportunity ( for me at least ). I will give some headlines out for now: MUSE, 1000 mg, Actis band. Perhaps other Urologists on the thread have had these experiences and can tell us about them because this appears to be spreading. these data has been coming out slowly the last 4-5 weeks in our metropolitan aerea. At least a dozen Urologists amongst whom is the largest group in this state.This is a tertiary care center also. Over 800 to 100 ED patients. As big a case load as Dr.I.Goldtstein's !Data are very exciting.

TA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext